SE7612262L - KETOPHOSPHONATE INTERMEDIATE PRODUCTS AND PROCEDURES - Google Patents

KETOPHOSPHONATE INTERMEDIATE PRODUCTS AND PROCEDURES

Info

Publication number
SE7612262L
SE7612262L SE7612262A SE7612262A SE7612262L SE 7612262 L SE7612262 L SE 7612262L SE 7612262 A SE7612262 A SE 7612262A SE 7612262 A SE7612262 A SE 7612262A SE 7612262 L SE7612262 L SE 7612262L
Authority
SE
Sweden
Prior art keywords
alpha
trans
dimethylisopropylsilyloxy
pentanor
indanyl
Prior art date
Application number
SE7612262A
Other languages
Swedish (sv)
Inventor
H-J E Hess
T K Schaaf
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of SE7612262L publication Critical patent/SE7612262L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0025—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing keto groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/30—Compounds having groups
    • C07C43/315—Compounds having groups containing oxygen atoms singly bound to carbon atoms not being acetal carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C62/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C62/30—Unsaturated compounds
    • C07C62/34—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4018—Esters of cycloaliphatic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/54—Quaternary phosphonium compounds
    • C07F9/5407—Acyclic saturated phosphonium compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

1456838 Silylated prostaglandins PFIZER Inc 8 Nov 1973 [8 Nov 1972] 51997/73 Heading C3S [Also in Division C2] N - Methansulphonyl - 15 - (5,6 - dimethoxy- 2 - indanyl) - 9α,11α,15# - tris - (dimethylisopropylsilyloxy) - 16,17,18,19,20 - pentanor - 13 - trans-prostenamide is prepared by hydrogenating N-methanesulphonyl-15-(5,6-dimethoxy-2- indanyl) - 9α,11α,15# - tris - (dimethylisopropylsilyloxy) - 16,17,18,19,20 - pentanor - 5 - cis, 13- trans-prostadienamide, resulting from the reaction between dimethylisopropylchlorosilane and N - methanesulphonyl - 9α,11α,15# - trihydroxy - 16,17,18,19,20 - pentanor - 5 - cis, 13- trans - prostadienamide. 16 - (2 - Indonyl)- 11α,15α - bis - (dimethylisopropylsilyloxy) - 9- oxo - 17,18,19,20 - tetranor - 13 - trans - prostenoic acid and 16-(2-indanyl)-11α,15α-bis-(dimethylisopropylsilyloxy) - 9 - oxo - 17,18.19,20- tetranor-5-cis, 13-trans-prostadienoic acid are obtained in a similar manner.
SE7612262A 1972-11-08 1976-11-03 KETOPHOSPHONATE INTERMEDIATE PRODUCTS AND PROCEDURES SE7612262L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30475072A 1972-11-08 1972-11-08

Publications (1)

Publication Number Publication Date
SE7612262L true SE7612262L (en) 1976-11-03

Family

ID=23177829

Family Applications (4)

Application Number Title Priority Date Filing Date
SE7315074A SE412229B (en) 1972-11-08 1973-11-06 ANALOGY PROCEDURE FOR PREPARING CERTAIN OMEGA-SUBSTITUTED PROSTAGLANDIN ANALOGS
SE7612261A SE7612261L (en) 1972-11-08 1976-11-03 PROSTAGLAND INTERMEDIATE PRODUCTS
SE7612262A SE7612262L (en) 1972-11-08 1976-11-03 KETOPHOSPHONATE INTERMEDIATE PRODUCTS AND PROCEDURES
SE7701523A SE417957B (en) 1972-11-08 1977-02-10 OMEGA-SUBSTITUTED PROSTAGLANDIN ANALOGUES FOR USE AS ANTIFERTILITY AGENT

Family Applications Before (2)

Application Number Title Priority Date Filing Date
SE7315074A SE412229B (en) 1972-11-08 1973-11-06 ANALOGY PROCEDURE FOR PREPARING CERTAIN OMEGA-SUBSTITUTED PROSTAGLANDIN ANALOGS
SE7612261A SE7612261L (en) 1972-11-08 1976-11-03 PROSTAGLAND INTERMEDIATE PRODUCTS

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE7701523A SE417957B (en) 1972-11-08 1977-02-10 OMEGA-SUBSTITUTED PROSTAGLANDIN ANALOGUES FOR USE AS ANTIFERTILITY AGENT

Country Status (20)

Country Link
JP (1) JPS5714347B2 (en)
AT (1) AT345999B (en)
BE (1) BE807046A (en)
CA (1) CA1033727A (en)
CH (1) CH593930A5 (en)
DE (1) DE2355731C3 (en)
DK (1) DK143499C (en)
ES (3) ES420386A1 (en)
FI (1) FI58912C (en)
FR (3) FR2205338B1 (en)
GB (1) GB1456838A (en)
IE (1) IE40043B1 (en)
IL (2) IL50310A (en)
IN (1) IN139265B (en)
NL (1) NL7315307A (en)
NO (2) NO143663C (en)
PH (2) PH13261A (en)
SE (4) SE412229B (en)
SU (2) SU667131A3 (en)
ZA (1) ZA738595B (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1431561A (en) * 1973-01-31 1976-04-07 Ici Ltd Cyclopentane derivatives
US3929862A (en) * 1974-01-08 1975-12-30 Upjohn Co Substituted tolylesters of PGF{HD 2{B {60
JPS5823393B2 (en) * 1974-03-14 1983-05-14 オノヤクヒンコウギヨウ カブシキガイシヤ prostaglandin
US4028396A (en) * 1975-07-02 1977-06-07 American Cyanamid Company 16,16-Spirocycloalkyl prostaglandin derivatives
NZ183136A (en) * 1976-02-11 1978-11-13 Miles Lab Monospiroalkyl derivatives of prostaclandis and pharmaceutical compositions
US4074063A (en) * 1976-02-11 1978-02-14 Miles Laboratories, Inc. Bicycloalkyl derivatives of prostaglandins
US4404372A (en) * 1977-06-13 1983-09-13 Pfizer Inc. 15-Substituted-ω-pentanorprostaglandin derivatives
DE2753995A1 (en) * 1977-12-03 1979-06-07 Bayer Ag NEW BICYCLOALKENYL PROSTAGLANDINS AND THE METHOD OF MANUFACTURING THEM
EP1021402B1 (en) * 1997-09-09 2005-11-23 Duke University Aromatic c16-c20-substituted tetrahydro prostaglandins useful as fp agonists
JP4619531B2 (en) * 1997-09-09 2011-01-26 デューク ユニバーシティ Aromatic C16-C20 substituted tetrahydroprostaglandins useful as FP agonists
AU731153B2 (en) * 1997-09-09 2001-03-22 Duke University Aromatic C16-C20-substituted tetrahydro prostaglandins useful as FP agonists
ATE281432T1 (en) 1999-03-05 2004-11-15 Univ Duke C-16 UNSATURATED FP-SELECTIVE PROSTAGLANDIN ANALOGUE
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US20020037914A1 (en) 2000-03-31 2002-03-28 Delong Mitchell Anthony Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
ES2326558T3 (en) * 2007-11-28 2009-10-14 Bauer Maschinen Gmbh LATHE.
US8623918B2 (en) 2008-10-29 2014-01-07 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US8722739B2 (en) 2008-10-29 2014-05-13 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US12565468B2 (en) * 2021-08-23 2026-03-03 Chirogate International Inc. Processes and intermediates for the preparations of Carboprost and Carboprost Tromethamine, and Carboprost Tromethamine prepared therefrom

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4864073A (en) * 1971-04-30 1973-09-05

Also Published As

Publication number Publication date
CH593930A5 (en) 1977-12-30
DE2355731C3 (en) 1981-01-15
FR2286147B1 (en) 1978-09-22
IL43571A0 (en) 1974-03-14
ES444398A1 (en) 1977-12-01
JPS49133357A (en) 1974-12-21
PH13320A (en) 1980-03-13
ES420386A1 (en) 1976-07-01
NO743616L (en) 1974-05-09
IE40043B1 (en) 1979-02-28
IE40043L (en) 1974-05-08
IN139265B (en) 1976-05-29
CA1033727A (en) 1978-06-27
IL50310A (en) 1977-08-31
DE2355731A1 (en) 1974-05-22
JPS5714347B2 (en) 1982-03-24
FR2291200B1 (en) 1979-01-05
DK143499B (en) 1981-08-31
SU667131A3 (en) 1979-06-05
NO143663C (en) 1981-03-25
SE412229B (en) 1980-02-25
FR2286147A1 (en) 1976-04-23
NO144385C (en) 1981-08-19
PH13261A (en) 1980-02-25
NO144385B (en) 1981-05-11
FR2291200A1 (en) 1976-06-11
FR2205338B1 (en) 1978-07-13
SE7612261L (en) 1976-11-03
SU704456A3 (en) 1979-12-15
SE417957B (en) 1981-04-27
AU6230273A (en) 1975-05-08
AT345999B (en) 1978-10-10
FI58912B (en) 1981-01-30
NO143663B (en) 1980-12-15
FR2205338A1 (en) 1974-05-31
DK143499C (en) 1982-01-11
ES456279A1 (en) 1978-11-01
DE2355731B2 (en) 1980-04-30
NL7315307A (en) 1974-05-10
BE807046A (en) 1974-05-08
GB1456838A (en) 1976-11-24
SE7701523L (en) 1977-02-10
ATA941073A (en) 1978-02-15
ZA738595B (en) 1974-09-25
IL43571A (en) 1977-08-31
FI58912C (en) 1981-05-11

Similar Documents

Publication Publication Date Title
SE7612262L (en) KETOPHOSPHONATE INTERMEDIATE PRODUCTS AND PROCEDURES
GB1409841A (en) Prostaglandins and the manufacture thereof
ES401979A1 (en) PROCEDURE FOR THE PREPARATION OF A PESTI-CIDE COMPOSITION.
ES444046A1 (en) Prostanoic acid derivatives
GB1456512A (en) Substituted 16,17,18,19,20-pentanorprostaglandins
SE7705945L (en) CYCLOPENTAN DERIVATIVES
AU6279773A (en) 8,12 prostaglandin analogues
ES430950A1 (en) 4-Hydroxy-3-nitro-5,6,7,8 tetrahydro-carbostyrils
SU604492A3 (en) Method of preparing pyrimidineaminomethylergoline derivatives
IT1052622B (en) PROCEDURE FOR PRODUCING I. PURE NITROANTRACHINONE
AU472988B2 (en) Cycloalkylidenol & cycloalkenol analogues of prostaglandins e & f
NO142789C (en) PROCEDURE FOR THE PREPARATION OF A POLYPEPTIDE ANTIBIOTIC, GARDIMYCIN.
SU568776A1 (en) Valve
SU483178A1 (en) Cutter for the single issue of blanks
AU476756B2 (en) PHARMACOLOGICALLY ACTIVE 4, 8-DIMETHOXY-FURO-(3',2'-F) BENZOXAZOL-2-yl ACETHYDROXAMIC ACID
AU462331B2 (en) Synthesis of 1, 2-butadiene
SE7505548L (en) PROCEDURE FOR FERMENTATIVE PRODUCTION OF PROTEIN.
GB1377036A (en) Process for the manufacture of a cast floor covering based on anhydrite
SE394815B (en) METHOD OF PREPARING CERTAIN STATEMENTS (3-BENZO-1,2,4-TRIAZINYL-DIOXIDE-1,4) URBAMIDES
ES205281Y (en) CLINICAL TABLE CONVERTIBLE INTO TABLE.
NO141158C (en) PROCEDURE FOR THE PREPARATION OF PURE TERTIARY OLEFINES.
CA874983A (en) SYNTHESIS OF N,N-DISUBSTITUTED .alpha.-AMINOACETYLENE THIOETHERS
AU485558B2 (en) N, n'disubstituted naphthaleneacetamidines
AU493176B2 (en) N 1 (3, 4-methylenedioxyphenyl) prop-2-yl) n'phenylpiperazine derivatives
AU8518775A (en) N, n'disubstituted naphthaleneacetamidines

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 7612262-1